Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-936P is a **pseudogene** in the human genome derived from the U6 small nuclear RNA (snRNA) gene family[2][5]. Pseudogenes like RNU6-936P do not encode functional snRNA molecules, though their sequences often closely resemble those of active genes. The **parental U6 snRNA** is a highly conserved small RNA involved in the spliceosome, catalyzing removal of introns from pre-mRNA during splicing in eukaryotic nuclei[1][3]. The presence of multiple pseudogenes related to U6 in vertebrate genomes reflects the evolutionary importance of the U6 RNA gene, but the pseudogenes themselves, including RNU6-936P, are not known to carry out any functional or regulatory roles and are not considered therapeutically relevant drug targets[2][5][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 936, pseudogene (RNU6-936P).